Search for: "AMGEN INC."
Results 481 - 500
of 704
Sorted by Relevance
|
Sort by Date
25 Jan 2019, 9:57 am
AMGEN INC. [read post]
25 Jan 2019, 9:57 am
AMGEN INC. [read post]
25 Jan 2019, 9:57 am
AMGEN INC. [read post]
9 Jun 2018, 7:01 pm
" Amgen Inc. v. [read post]
5 Jan 2009, 9:09 pm
District Court, ($250) Michelle Lerach (.pdf), Coughlin Stoia Geller Rudman & Robbins ($50,000) Dianna Lyons, Kazan, McClain, Abrams, Lyons, Greenwood & Harley ($2,500) Duane Lyons, Quinn Emanuel Urquhart Oliver & Hedges ($10,000) Steve Madison, Quinn Emanuel Urquhart Oliver & Hedges ($10,000) Nion McEvoy, Chronicle Books ($500) Jeffery McFarland, Quinn Emanuel Urquhart Oliver & Hedges ($50,000) Patricia McQuater, Solar Turbines ($12,500) Bettina… [read post]
1 Feb 2016, 8:11 am
Cir. 2012) (quoting Amgen Inc. v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
24 Aug 2012, 4:33 pm
Relying on our decision in Amgen Inc. v. [read post]
1 May 2014, 9:00 am
John Fund, Inc. [read post]
21 Jan 2013, 1:39 am
The Court already has the Amgen case on its docket this term; the Amgen case has already been argued and the Court’s decision in expected before the end of the current term in June. [read post]
30 Jul 2015, 9:50 am
That is what today's decision addresses.Appeal to the Supreme CourtThe Court of Appeal has refused leave for Smith & Nephew to appeal to the Supreme Court, because it considered that there is no significant point of general public importance at stake, since it has done no more than apply the established principles of claim construction from Kirin Amgen (Kirin Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46, [2005] RPC 9) to the case before it. [read post]
19 Oct 2015, 1:39 pm
Cir. 2010)(quoting Amgen Inc. v. [read post]
27 Jan 2014, 11:40 am
Ed. 2d 179 (2007) (noting that courts ruling on 12(b)(6) motions to dismiss may take into consideration "matters of which a court may take judicial notice"); In re Amgen Inc. [read post]
31 Jul 2013, 4:25 pm
Medline Industries, Inc.). [read post]
8 Feb 2017, 3:09 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
26 Sep 2022, 4:49 am
Full Scope Enablement in Amgen Inc. v. [read post]
1 Apr 2011, 12:42 pm
" Amgen Inc. v. [read post]
7 Oct 2013, 11:06 am
” Power-One, 599 F.3d at 1351; Amgen Inc. v. [read post]
14 Nov 2016, 9:16 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
